Skip to content

Comparison of coloninc cleansing methods for patients undergoing surgery of colorectal cancer

Comparison of coloninc cleansing methods for patients undergoing surgery of colorectal cancer - Comparison of coloninc cleansing methods

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000016693
Enrollment
200
Registered
2015-03-04
Start date
2015-02-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

None listed

Sponsors

Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who fills everything the following (1)Age of patients is above 20 years old (2)Patients who were able to provide written informed consent for articipation in this study

Exclusion criteria

Exclusion criteria: (1) Patients who have or who are suspected to have gastrointestinal obstruction (2) Patients who have or who are suspected to have gastrointestinal perforation (3) Patients who have or who are suspected to have toxic megacolon (4) Patients who have or who are suspected to have delayed gastric empty (5) Patients who have glucose-6-phosphate dehydrogenase deficiency (6) Patients who have renal dysfunction(blood urea nitrogen (BUN) >= 25 mg/dL, serum creatinine >= 2 mg/dL) (7) Patients who have gastrointestinal stenosis (8) Patients who have impaired vomiting reflex or risk of aspiration (9) Patients who are dehydrated (10) Patients who are under or need any treatments for severe cardiac disease (angina, cardiac infarction) or liver dysfunction (serum total bilirubin >= 3.0 mg/dL, ALT or AST >= 100 IU/L) (11) Patients who have allergy of the drugs (12) Patients who are pregnant or under lactation, or who would be expected to be pregnant during the study (13) Patients who are not eligible due to physician's judgment (14) Patients who are hospitalized for reasons other than taking colonoscopy (15) Patients who receive intravenous hyperalimentation or enteral nutrition

Design outcomes

Primary

MeasureTime frame
acceptability of colonic cleansing methods

Secondary

MeasureTime frame
frequency of bowel movement, dose of standard and low-volume polyethylene glycol, Time to first defecation, duration of taking medicine, Time to start examination

Countries

Japan

Contacts

Public ContactKoji Okabayashi

Keio University School of Medicine Departement of Surgery

okabayashikoji@gmail.com03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026